Opioid
overdose treatment involves the use of pharmaceutical drugs and therapies to
reverse the effects of opioids during an opioid overdose. Some common
treatments for opioid overdose include naloxone, buprenorphine, and methadone.
Naloxone is considered the frontline treatment for reversing opioid overdose as
it works by blocking opioid receptors and reverting the life-threatening
depression of the central nervous and respiratory systems. The need for opioid
overdose treatment has been growing due to the rising misuse of prescription
and illegal opioids. According to the National Institute on Drug Abuse, more
than 500,000 Americans died from drug overdoses during 1999-2019, with 70% of
these deaths involving an opioid.
The Global Opioid
Overdose Treatment Market is estimated to be valued at US$ 45.9 Bn in 2024
and is expected to exhibit a CAGR of 6.1% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the Opioid Overdose Treatment are Enalare Therapeutics
Inc., Opiant Pharmaceuticals, Hikma Pharmaceuticals, Emergent BioSolutions,
Purdue Pharma. Enalare Therapeutics is developing a novel intranasal nalmefene
formulation to reverse opioid overdoses. Opiant Pharmaceuticals' lead opioid
overdose drug, Narcan Nasal Spray, received regulatory approvals in the United
States and Europe.
The key opportunities in the opioid overdose treatment market include the
commercialization of emerging pipeline drugs with enhanced safety profiles and
abuse-deterrent formulations. There is also a need to develop innovative
delivery mechanisms for opioid antagonists to allow for self- or
community-administration during opioid emergencies.
The market is witnessing significant expansion outside the United States as
well. Several countries in Europe, Asia Pacific, Latin America, Middle East,
and Africa are also impacted by the increasing opioid crisis. This has accelerated
the adoption of opioid overdose treatment medications across international
markets.
Market drivers
The growing availability and misuse of both prescription and illegal opioids is
a key driver augmenting the need for opioid overdose treatments. According to
CDC data, prescription opioids were involved in more than 17,000 overdose
deaths in 2017 alone. This rising wave of opioid abuse and overdoses has
increased the demand for opioid overdose reversal drugs. Moreover, the
guidelines emphasizing increased naloxone access and broader prescription of
naloxone to high-risk groups will continue driving market revenues.
Market restraints
Lack of opioid antagonist access in developing countries pose a major
restraint. Naloxone availability remains limited in low and middle-income
nations where the disease burden is also significant. The high costs associated
with branded opioid overdose drugs also restrain market potential,
necessitating generic competition and value-based pricing strategies.
Non-acceptance of opioid dependence as a public health issue by certain
regional governments further impedes market progress.
Segment Analysis
The opioid overdose treatment market is segmented based on treatment type
into nasal spray drugs, injection drugs, and others. Among these, the injection
drugs segment dominates currently as Naloxone is widely used in injection form
to treat opioid overdose in emergency situations. Naloxone in injection form
gets absorbed into the body quickly to reverse overdose effects within 2-5
minutes.
Global Analysis
The North America region dominates the global opioid overdose treatment
market currently. This is due to the increasing number of opioid overdoses in
the US. According to CDC data, over 100,000 drug overdose deaths were reported
in the US in 2021, out of which majority involved opioids. The emergency
medical services and first responders in the US extensively use naloxone in
injection form to rapidly reverse overdoses. Europe is also a major regional
market and is expected to witness fastest growth during the forecast period due
to growing availability of easy-to-administer formulations such as nasal spray
drugs for opioid overdose reversal in several European countries.
Get more insights on this topic : https://justpaste.it/hruqm
What
Are The Key Data Covered In This Opioid Overdose Treatment Market Report?
:- Market
CAGR throughout the predicted period
:- Comprehensive
information on the aspects that will drive the Opioid Overdose Treatment 's
growth between 2024 and 2031.
:- Accurate
calculation of the size of the Opioid Overdose Treatment and its contribution to the market, with
emphasis on the parent market
:- Realistic
forecasts of future trends and changes in consumer behaviour
:- Opioid
Overdose Treatment Industry Growth in
North America, APAC, Europe, South America, the Middle East, and Africa
:- A
complete examination of the market's competitive landscape, as well as
extensive information on vendors
:- Detailed
examination of the factors that will impede the expansion of Opioid Overdose
Treatment vendors
About Author:
Ravina Pandya, Content Writer, has a strong foothold
in the market research industry. She specializes in writing well-researched
articles from different industries, including food and beverages, information
and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
*Note:
1.
Source: Coherent Market Insights, Public sources, Desk research
2.
We have leveraged AI tools to mine information and compile it
Comments
Post a Comment